CD4+CD62L+ Central Memory T Cells Can Be Converted to Foxp3+ T Cells by Zhang, Xiaolong et al.
 CD4+CD62L+ Central Memory T Cells Can Be Converted to
Foxp3+ T Cells
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Zhang, Xiaolong, Xian Chang Li, Xiang Xiao, Rui Sun, Zhigang
Tian, and Haiming Wei. 2013. “CD4+CD62L+ Central Memory T
Cells Can Be Converted to Foxp3+ T Cells.” PLoS ONE 8 (10):
e77322. doi:10.1371/journal.pone.0077322.
http://dx.doi.org/10.1371/journal.pone.0077322.
Published Version doi:10.1371/journal.pone.0077322
Accessed February 19, 2015 2:40:46 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11878889
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
CD4+CD62L+ Central Memory T Cells Can Be Converted to
Foxp3+ T Cells
Xiaolong Zhang1, Xian Chang Li2, Xiang Xiao2, Rui Sun1,3, Zhigang Tian1,3*, Haiming Wei1,3*
1 Institute of Immunology, School of Life Sciences, University of Science & Technology of China, Hefei, Anhui, China, 2 Transplant Research Center, Brigham
and Women's Hospital & Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America, 3 Hefei National Laboratory for
Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui, China
Abstract
The peripheral Foxp3+ Treg pool consists of naturally arising Treg (nTreg) and adaptive Treg cells (iTreg). It is well
known that naive CD4+ T cells can be readily converted to Foxp3+ iTreg in vitro, and memory CD4+ T cells are
resistant to conversion. In this study, we investigated the induction of Foxp3+ T cells from various CD4+ T-cell subsets
in human peripheral blood. Though naive CD4+ T cells were readily converted to Foxp3+ T cells with TGF-β and IL-2
treatment in vitro, such Foxp3+ T cells did not express the memory marker CD45RO as do Foxp3+ T cells induced in
the peripheral blood of Hepatitis B Virus (HBV) patients. Interestingly, a subset of human memory CD4+ T cells,
defined as CD62L+ central memory T cells, could be induced by TGF-β to differentiate into Foxp3+ T cells. It is well
known that Foxp3+ T cells derived from human CD4+CD25- T cells in vitro are lack suppressive functions. Our data
about the suppressive functions of CD4+CD62L+ central memory T cell-derived Foxp3+ T cells support this
conception, and an epigenetic analysis of these cells showed a similar methylation pattern in the FOXP3 Treg-
specific demethylated region as the naive CD4+ T cell-derived Foxp3+ T cells. But further research showed that
mouse CD4+ central memory T cells also could be induced to differentiate into Foxp3+ T cells, such Foxp3+ T cells
could suppress the proliferation of effector T cells. Thus, our study identified CD4+CD62L+ central memory T cells as
a novel potential source of iTreg.
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Introduction
Regulatory T cells play an important role in self-tolerance,
acquired tolerance, and immunological homeostasis [1,2].
There are multiple types of immune regulatory T cells, including
Tr1 cells, natural killer T cells, CD8+ T cells and
CD4+CD25+Foxp3+ cells [3]. CD4+CD25+Foxp3+ cells (referred
to as Treg) are the predominant regulatory T cells. Treg, which
are defined by their expression of Foxp3, are broadly
subdivided into nTreg and iTreg [4]. nTreg are generated by
the interactions between thymic T cell receptors (TCRs) with a
high affinity for MHC class II ligands in the thymus. These cells
help to maintain tolerance to self-antigens to prevent
autoimmunity and to regulate immune responses by raising
activation thresholds. Induced Treg cells are potentially derived
from various conditions outside the thymus, a phenomenon
that has been supported by numerous in vivo studies [4].
Although it is clear that iTreg are converted from activated T
effector cells in the periphery, the origin of activated T effector
cells is unclear. Previous in vivo evidence has suggested that
iTreg are derived from conventional CD4+CD25- T cells in the
periphery [5-7]. Further in vitro studies supported this notion, as
iTreg can be efficiently differentiated from purified CD4+CD25-
T cells via TGF-β stimulation [8]. Recently, other studies
reported that of the CD4+CD25- T cells, only naive CD4+ T cells
(Tn) but not memory CD4+ T cells (Tm) are able to differentiate
into iTreg in vitro in both mouse and human models [9-12]. It is
generally accepted that iTreg are converted from activated
naive CD4+CD25- T cells in vivo. Although naive CD4+CD25-- T
cells can be converted into iTreg by TGF-β, the ability of
memory CD4+CD25-- T cells to differentiate into iTreg remains
controversial. One report has shown that human Foxp3+ iTreg
are derived from the rapid turnover of peripheral memory
CD4+Foxp3- T cells in vivo, and another found that mouse Th2
memory T cells can be efficiently converted into Foxp3+ iTreg in
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vitro using a differentiation protocol [13,14]. Additionally,
human skin-derived memory Th cells can be converted into
Foxp3+ iTreg with a suitable manipulation [15]. These studies
revealed the possibility that memory CD4+CD25-- T cells can
differentiate into iTreg. As human memory CD4+CD25-- T cells
are not a uniform population (like naive CD4+CD25- T cells)
[16], various subsets of memory CD4+ T cells may have
different capabilities for differentiating into iTreg. Thus, we
cannot exclude the possibility that iTreg are converted from
activated memory CD4+CD25- T cells in vivo. Because iTreg
play essential roles in the development of immune tolerance to
foreign antigens and tumour-derived neo-antigens [17,18], a
better understanding of their origin and differentiation would
provide important information regarding their therapeutic
potential.
Here, we showed that human memory CD4+CD25- T cells
could be efficiently differentiated into Foxp3+ T cells via TCR
activation with TGF-β, but this phenomenon was restricted to
CD62L+CCR7+ memory CD4+ T cells. Furthermore, we also
found this phenomenon in mice and proved that such
CD4+CD62L+ central memory T cell-derived Foxp3+ T cells
were functional in suppressing the proliferation of T effector
cells. Our data suggest that CD4+CD62L+ central memory T
cells can be differentiated into functional Foxp3+ iTreg, at least
in mice. These findings may have important implications for
understanding the development of iTreg in vivo.
Materials and Methods
Ethics Statement
Healthy human peripheral blood was obtained from the
Blood Centre of Anhui Province (Hefei, China). Peripheral
blood was obtained from chronic HBV-infected and healthy
women at the Centre for Disease Control and Prevention in
Hefei, China. Ethical approval to use these samples was
obtained from the Ethics Committee of the University of
Science and Technology of China (Permit Number:
USTCACUC1201011). In accordance with the Declaration of
Helsinki and the Institutional Review Board of the University of
Science and Technology of China, all participants provided
written informed consent, which was obtained before enrolment
in the study.
The study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals. A GFP-Foxp3 fusion protein was created
by introducing a bicistronic enhanced GFP reporter gene into
the endogenous Foxp3 loci of B6 mice (foxp3gfp), as previously
reported [19]. These knock-in mice were bred and maintained
at Harvard Medical School in Boston. All protocols involving
animal work were approved by the Animal Care and Use
Committee at Harvard Medical School (Permit Number:
004848). All surgery was performed under anaesthesia, and all
efforts were made to minimize animal suffering.
Cell purification
Peripheral blood mononuclear cells (PBMCs) were prepared
by centrifugation over Ficoll-Hypaque gradients and then
stained with APC-Cy7-anti-CD4, PE-anti-CD25, FITC-anti-
CD45RA, and APC-anti-CD45RO (or APC-Cy7-anti-CD4, PE-
anti-CD25, FITC-anti-CD62L, APC-anti-CD45RO, PE-Cy7-anti-
CCR7) for 30 min at 4°C. The CD45RA+CD45RO- (naive) and
CD45RA-CD45RO+ (memory) cells within the CD4+CD25-
family were gated and selectively sorted with a FACSAria flow
cytometer. CD62L+CCR7+ naive, CD62L+CCR7+ memory,
CD62L+CCR7- memory, and CD62L-CCR7- memory cells within
the CD4+CD25- family were obtained as above. For the
isolation of naive, central memory, and effector memory CD4 T
cells from Foxp3gfp mice, mouse spleen cells were prepared
and stained with PE-Cy5-anti-CD4, PE-Cy7-anti-CD44, and
Pacific Blue-anti-CD62L for 20 min at 4°C. The
CD44lowCD62Lhigh cells (naive), CD44highCD62Lhigh cells (central
memory) and CD44highCD62Llow cells (effector memory) within
the CD4+ GFP (Foxp3)- family were gated and selectively
sorted. The purity of sorted cells was higher than 95%. The
antibodies used above were all from BD Bioscience (SanJose,
CA)
Conversion of CD4+Foxp3- T cells into Foxp3+ T cells in
vitro
Peripheral blood mononuclear cells (PBMCs) were prepared
by centrifugation over Ficoll-Hypaque gradients from healthy
human peripheral blood. Naive, memory, central memory and
effector memory human CD4 T cells were sorted from the
prepared PBMCs. The FACS-sorted human CD4 T cells were
stimulated in vitro (5×104 cells/well) with plate-bound anti-CD3
(5 μg/ml; BD Bioscience) and soluble anti-CD28 (1 μg/ml; BD
Bioscience) for 1–7 days in the presence of recombinant
human TGF-β (5 ng/ml; R&D) and IL-2 (100 U/ml; Peptech) or
not. The induction of Foxp3+ T cells in the CD4+ fraction was
analysed by FACS based on the intracellular staining of the
Foxp3 protein. FACS-sorted mouse naive, central memory, and
effector memory CD4 T cells were stimulated in vitro (1×105
cells/well) with anti-CD3 (2 μg/ml; BD Pharmingen) and APCs
(1×105 cells/well) in the presence of recombinant TGF-β (3
ng/ml; R&D) and IL-2 (100 U/ml; Peptech) for 3–5 days. APCs
were obtained from syngeneic mice by depleting T cells from a
population of spleen cells and then treating them with
mitomycin C (50 μg/ml; Sigma-Aldrich) at 37°C for 20 min. The
induction of Foxp3+ T cells in the CD4+ fraction was analysed
by FACS based on the expression of GFP.
Flow cytometric analysis
For intracellular Foxp3 and CTLA-4 staining, cultured cells
were resuspended and labelled with the fluorochrome-
conjugated specific mAbs against surface markers for 30 min
at 4°C. The cells were then fixed and permeabilised using the
Fixation/Permeabilization intracellular staining kit according to
the manufacturer’s protocol (eBioscience). After fixation and
permeabilisation, cells were incubated with Percp-cy5.5-anti-
FOXP3 (eBioscience) and PE-anti-CTLA-4 (BD Bioscience)
Abs. Data were acquired with a FACSCalibur flow cytometer
(BD Bioscience) and analysed with FlowJo software (Tree
Star).
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Suppression assays in vitro
Human naive CD4+ T cells, CD62L+CCR7+ central memory
CD4+ cells, and CD62L-CCR7- effector memory CD4+ cells
were stimulated in vitro (5×104 cells/well) for 5 days in the
presence of TGF-β and IL-2. After stimulation, the cells were
harvested, rested for 2 days in IL-2-containing culture medium
and then washed three times with PBS prior to the suppression
assay. These cells were used as suppressor cells. CD4+CD25-
T cells, CD4+CD25high Treg cells and CD3- PBMCs were
purified from healthy human PBMCs. CD4+CD25- T cells
labelled with 5 mM CFSE (Invitrogen) were used as responder
T cells (Teff), and irradiated CD3- PBMCs (3000 rad) were used
as antigen-presenting cells (APCs) in suppression assays. The
labelled T cells (2.5×104 cells/well) were co-cultured with
varying numbers of CD4+CD25high Treg or induced Foxp3+ T
cells to achieve the desired Treg/Teff cell ratios. The cells were
then stimulated in vitro either with or without APCs (5×104 cells/
well) prior to stimulation with 5 μg/mL anti-CD3 and with or
without 1 μg/mL anti-CD28 in 96-well culture plates in
supplemented RPMI medium for 5 days. Responder T cell
proliferation with or without induced Foxp3+ T cells was
assessed using flow cytometric CFSE dilution after 5 days.
CD4+GFP (Foxp3-) T cells were sorted from Foxp3gfp mice,
labelled with CFSE and used as responder cells. The labelled
T cells (1×105 cells/well) were mixed with varying numbers of
GFP+ (Foxp3+) T cells to achieve the desired Treg/T effector
cell ratios. CD4+GFP+ (Foxp3+) T cells were sorted from naive
or central memory CD4+ T cells through the induction of Foxp3.
The cell mixture was stimulated with syngeneic APCs (1×105
cells/well) and anti-CD3 (1 μg/ml). The T cell-depleted spleen
cells were briefly treated with mitomycin C and used as APCs.
After 3 days, responder T cell proliferation with or without
Foxp3+ T cells was assessed using flow cytometry based on
the dilution of the CFSE dye.
FOXP3 Treg-specific demethylated region (TSDR) DNA
methylation analysis
Cells for this series of experiments were from normal male
donor peripheral blood to avoid the problems with interpretation
from X-chromosomal inactivation of one FOXP3 allele in the
methylation analysis. FACS-sorted naive and CD62L+ central
memory CD4+ cells were stimulated for 5 days in the presence
of IL-2 (100 U/ml) with or without TGF-β. Sorted CD4+CD25high
Tregs were stimulated for 5 days in the presence of IL-2 (300
U/ml) as a control. Genomic DNA of cultured cells was
extracted by using the EasyPureTM Genomic DNA kit
(TransGen Biotech) according to the manufacturer’s protocol
for cultured mammalian cells. Bisulfite conversion of genomic
DNA was performed by the EZ DNA Methylation-Gold™ Kit
(ZYMO RESEARCH) according to the manufacturer’s
instructions. DNA was then subjected to PCR with the following
TSDR-primers (5’ to 3’ direction): forward –
TGTTTGGGGGTAGAGGATTT and reverse –
TATCACCCCACCTAAACCAA [20]. PCR was performed in a
final volume of 25 μl containing 1x PCR Buffer, 1.25 U Taq
DNA polymerase (TaKaRa, LA Taq Hot Start Version), 200 mM
dNTPs, 100 pmol each of forward and reverse primers, and 2
μl of bisulfite-treated genomic DNA at 95°C for 10 min and 40
cycles of 95°C for 1 min, 55°C for 45 sec and 72°C for 1 min
with a final extension step of 10 min at 72°C. PCR products
were purified using the Wizard SV Gel and PCR Clean-Up
System (Promega). The purified PCR products were then
cloned into the pMD19-T vector (TaKaRa), and 15 individual
clones from each sample were cycle sequenced by the ABI
3730 genetic analyzer (Applied Biosystems). DNA methylation
analysis and diagram generation were performed by BiQ
Analyzer [21].
Statistical analysis
GraphPad Prism 5.00 software (GraphPad) was used to
compare the difference among different groups by using the
unpaired t test, when values at p<0.05 were considered as
significant.
Results
The surface expression of CD45RO distinguishes
between human induced CD4+Foxp3+ T cells
populations in vitro and in vivo
Human CD4+Foxp3+ T cells are phenotypically
heterogeneous and include the CD45RO+ and CD45RA+ T cell
subtypes [22,23]. To examine the phenotype of CD4+Foxp3+ T
cells induced in vivo, PBMCs from chronic HBV-infected
women in the inactive (IN) phase (n=38) and from healthy
women (n=22) were analysed by flow cytometry, detailed
information on the patient’s ages are shown in Table S1. We
first gated on CD4+ cells from the PBMCs (Figure 1A) and
found that the proportion of CD4+Foxp3+ T cells was
significantly higher in chronic HBV-infected women than in the
healthy controls (3.271±0.1394 vs. 2.055±0.1200; P<0.0001)
(Figure 1B). We also observed a significantly higher proportion
of CD45RO+Foxp3+ T cells in the PBMCs of chronic HBV-
infected women compared to the healthy controls
(2.257±0.1111 vs. 1.130±0.08875; P<0.0001) (Figure 1B). We
then gated on CD4+Foxp3+ cells from the PBMCs (Figure 1C)
and further confirmed a significantly higher proportion of
CD45RO+ cells in the CD4+Foxp3+ cells of chronic HBV-
infected women compared to the healthy controls (67.49±1.117
vs. 48.27±1.857; P<0.0001) (Figure 1D). These results
suggested that the induced Foxp3+ T cells in the peripheral
blood of HBV patients expressed the memory marker
CD45RO.
We further examined whether CD4+Foxp3+ T cells induced in
vitro had the same CD45RO expression as CD4+Foxp3+ T cells
induced in vivo. We purified CD4+ naive T cells from human
PBMCs and induced CD4+Foxp3+ by T-cell receptor (TCR)
activation in vitro. We found that the CD4+ naive T cells that
were activated either by TCR stimulation alone or together with
TGF-β and IL-2 rarely co-expressed CD45RO and Foxp3
(Figure 1E). When we analysed the expression of CD45RA, we
found that naive CD4+ T cells showed no CD45RA expression
under stimulation in vitro (Figure S1).
The above results collectively show that CD4+Foxp3+ T cells
generated in vitro through TCR stimulation express different
levels of CD45RO than in vivo chronic virus infection-induced
CD4+Foxp3+ T cells, which suggests that CD4+Foxp3+ T cells
Induced Foxp3+ T Cells from CD4+ Memory T Cells
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induced in vivo might not all be derived from CD4+ naive T
cells.
A small portion of human CD4+ memory T cells can
differentiate into Foxp3+ T cells by TGF-β stimulation
CD4+ naive (Tn) and memory (Tm) T cells from healthy
human PBMCs were sorted using flow cytometry and
investigated for their in vitro induction of Foxp3 in the presence
or absence of TGF-β/IL-2 (Figure 2A). Consistent with previous
studies in human and mouse CD4+ T cells, we showed that
TGF-β-mediated Foxp3 expression was significantly higher in
CD4+ naive T cells than in CD4+ memory T cells. However, a
small undefined population of CD4+ memory T cells was
induced to express Foxp3 (Figure 2B).
Treg express several inhibitory molecules, such as CTLA-4,
PD-1, and PD-L1, which are potentially necessary for their
suppressive functions [24-26]. We analysed the expression of
these molecules by flow cytometry before and after stimulation
with TGF-β. Prior to stimulation, the expression levels of
membrane CTLA-4 and PD-L1 were not significantly different
Figure 1.  Differential CD45RO expression between Foxp3+ T cells differentiated in vivo by chronic viral infection and in
vitro by TCR stimulation.  (A) Flow cytometric analysis of Foxp3 expression by CD4+ PBMCs of 4 HBV-infected patients (upper
panels) and 4 healthy controls (lower panels). The frequency of cells in each quadrant is displayed as numbers in the quadrants. (B)
The average percentages of CD45RO+Foxp3+, CD45RO-Foxp3+ and Foxp3+ cells in the pools of CD4+ cells from 38 HBV-infected
patients and 23 healthy controls. (C) Flow cytometric analysis of CD45RO expression by CD4+Foxp3+ PBMCs of 4 HBV-infected
patients (upper panels) and 4 healthy controls (lower panels). The frequency of cells in each quadrant cells is displayed as numbers
in the quadrants. (D) The average percentages of CD45RO+ and CD45RO- cells among pools of CD4+Foxp3+ cells from 38 HBV-
infected patients and 23 healthy controls. (E) Naive CD4+ T cells were sorted from adult peripheral blood by FACS, and the cells
were activated with plate-bound anti-CD3 (5 μg/ml) and soluble anti-CD28 (1 μg/ml) in the absence or presence of TGF-β (5 ng/ml)
and IL-2 (100 UI/ml) for 5 days. The cells were then collected and analysed by flow cytometry to evaluate the expression of Foxp3
and CD45RO.
doi: 10.1371/journal.pone.0077322.g001
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between CD4+ naive and memory T cells. However, PD-1 was
expressed in CD4+ memory but not naive T cells. In addition,
both CD4+ naive and memory T cells expressed intracellular
CTLA-4, but the expression level was significantly higher in
memory T cells (Figure 2C,E). After stimulation, the CD4+
memory T cells cultured with TGF-β expressed higher levels of
membrane CTLA-4 than CD4+ naive T cells. The total cytosolic
and membrane CTLA-4 expression levels were similar between
the cell populations. The expression levels of PD-L1 and PD-1
were also similar between the two cell populations (Figure
2D,F).
The above results showed that, although CD4+ memory T
cells were resistant to TGF-β-mediated Foxp3 expression, they
expressed higher levels of membrane CTLA-4 than CD4+ naive
T cells. The high level of membrane CTLA-4 expression in
memory CD4+ T cells that is observed upon Foxp3 induction
Figure 2.  Small portion of human CD4+ memory T cells can be converted to Foxp3+ T cells in vitro.  (A) CD4+ naive (Tn) and
memory (Tm) T cells were sorted and activated with plate-bound anti-CD3 (5 μg/ml) and soluble anti-CD28 (1 μg/ml) in the
presence or absence of TGF-β (5 ng/ml) and IL-2 (100 UI/ml). Foxp3 expression was analysed by flow cytometry at different time
points as indicated. (B) The average percentages of Foxp3 expression in CD4+ naive and memory T cells on day 5 after TGF-β and
IL-2 induction. (C) and (E) Flow cytometric analysis of CTLA-4 (extracellular and total), PD-1, and PD-L1 expression in total, freshly
sorted, naive (Tn) or memory (Tm) CD4+ T cells. (D) and (F) Sorted CD4+ naive (Tn) or memory (Tm) T cells were activated for 5
days as described above, and the total population was analysed using flow cytometry for the expression of CTLA-4 (extracellular
and total), PD-1, and PD-L1.
doi: 10.1371/journal.pone.0077322.g002
Induced Foxp3+ T Cells from CD4+ Memory T Cells
PLOS ONE | www.plosone.org 5 October 2013 | Volume 8 | Issue 10 | e77322
and the fact that some CD4+ memory T cells can be induced to
express Foxp3 suggest that a special subset of CD4+ memory
T cells might have the ability to differentiate into Foxp3+ T cells.
Thus, we next explored the ability of different subsets of CD4+
memory T cells to differentiate into Foxp3-expressing T cells.
CD4+CD62L+ central memory T cells can differentiate
into Foxp3+ T cells with TGF-β treatment
Human memory T cells can be divided into central memory
and effector memory cells based on CCR7 expression. Thus,
we sorted human CD4+ memory T cells into CCR7+ (central
memory, Tcm) and CCR7- (effector memory, Tem) T cells and
compared their responsiveness to TGF-β stimulation. The
results showed that the differentiation efficiency of central
memory T cells was higher than that of effector memory T cells
(Figure 3A). Although the CD4+ central memory T cells were
induced into Foxp3+ T cells more efficiently than the effector
memory T cells, the rate of differentiation was still lower than
that of CD4+ naive T cells. This led us to perform a more
detailed surface marker analysis of the CD4+ central memory T
cell pool. This analysis identified a group of cells that were
doubly positive for CD62L and CCR7 and had a similar surface
expression phenotype to CD4+ naive T cells (Figure 3B).
Because CD4+CD45RO- T cells express a high level of
CD45RA (Figure S2), we considered CD4+CD45RO- T cells to
be CD4+CD45RA+ naive T cells. We then isolated these groups
of CD4+ memory T cells based on CD62L and CCR7
expression and examined their response to TGF-β induction.
As expected, the differentiation efficiency of CD4+CD62L+
central memory T cells was close to that of CD4+ naive T cells,
while the other types of CD4+ memory T cells differentiated at
low rates (Figure 3, C and D).
Foxp3+ T cells derived from human CD4+CD62L+ central
memory cells in vitro do not exhibit apparent
suppressive functions
We next examined whether Foxp3+ T cells derived from
different subsets of human CD4+ T cells were functionally
similar to Treg. We used induction procedures to differentiate
Foxp3+ T cells from naive CD4+ T cells, CD62L+CCR7+ memory
CD4+ T cells, and CD62L-CCR7- memory CD4+ T cells before
further evaluating their suppressive function by co-culture with
varying ratios of responder CD4+CD25- T cells. The CFSE
proliferation study showed that the Foxp3+ T cells induced from
the CD62L+CCR7+ memory cells did not exhibit the expected
suppressive functions, as they were unable to suppress the
responder CD4+CD25- T cells even when stimulated at 1:1
(Foxp3+ T cells/Teff cell) ratio (Figure 4A). The Foxp3+ T cells
derived from naive CD4+ T cells displayed weak suppressive
functions similar to the Foxp3+ T cells derived from CD62L
+CCR7+ memory cells, which is consistent with a previous study
showing that Foxp3+ T cells induced from naive CD4+ T cells by
TGF-β and IL-2 treatment did not exhibit suppressive
capabilities [12]. In addition, the Foxp3+ T cells induced from
CD62L-CCR7- memory CD4+ T cells did not exhibit any
suppressive functions and even somewhat enhanced
responder cell proliferation. We obtained the same results
using another assay system in which APCs plus anti-CD3 were
used stimulate the responder CD4+CD25- T cells (Figure S3).
Foxp3+ T cells derived from human CD4+CD62L+ central
memory cells in vitro showed high methylation levels
of FOXP3 TSDR
In Treg, the FOXP3 Treg-specific demethylated region
(TSDR) is fully demethylated, and demethylation correlates
with sustained Foxp3 expression. It was previously
demonstrated that Foxp3+ T cells derived from human CD4+
naive T cells have poor suppressive functions, and this is likely
because the TGF-β-mediated Foxp3 expression in these cells
does not epigenetically alter the methylation status of the
FOXP3 TSDR [20,27,28]. To examine whether the weak
suppressive functions of the Foxp3+ T cells derived from
human CD4+CD62L+ central memory cells correlated with a
high methylation status of the FOXP3 TSDR, we induced
Foxp3+ T cells from FACS-sorted human CD4+ naive and
CD4+CD62L+ central memory cells in vitro. Sorted
CD4+CD25high Tregs, CD4+ naive and CD4+CD62L+ central
memory cells were stimulated in vitro as controls. The
methylation statuses of 15 CpG sites in the TSDR sequences
were analysed (Figure 4B-C). The analysis revealed higher
levels of TSDR methylation in the CD4+CD62L+ central memory
cell-derived Foxp3+ T cells than in the sorted Tregs, although
these sites had less TSDR methylation than CD4+ naive T cell-
derived Foxp3+ T cells. The TSDR methylation status in the
control experimental groups (sorted CD4+CD25high Tregs, CD4+
naive and CD4+CD62L+ central memory cells) was consistent
with a previous report [20].
Mouse CD4+CD62L+ central memory T cells readily
convert to functional Foxp3+ regulatory T cells
Foxp3+ T cells can be induced from murine naive CD4+ T
cells by TGF-β and IL-2 and simultaneously obtain suppressive
functions, which is different from human naive CD4+ T cells.
This indicates that other unknown factors participate in the
conversion of human Foxp3- T cells to Foxp3+ iTreg [12]. We
did not observe any suppressive activity of Foxp3+ T cells
derived from CD4+CD62L+ central memory cells, likely for the
same reason. Although it has been reported that mouse
CD4+Foxp3- effector memory T cells (CD44highCD62L-) are
resistant to TGF-β-induced Foxp3 expression [10], it remains
unknown whether mouse CD4+Foxp3- central memory cells
(CD44highCD62L+) exhibit the same property. To confirm this
phenomenon, we sorted murine naive (CD44lowCD62L+),
central memory (CD44highCD62L+), and effector memory
(CD44highCD62L-) cells from the CD4+GFP- (Foxp3-) T cell pool
of Foxp3gfp mice by FACS. We then stimulated the cells in vitro
with syngeneic APCs and soluble anti-CD3 in the presence of
TGF-β and IL-2 and analysed the induction of Foxp3+ T cells by
flow cytometry at different time points. As expected, mouse
CD4+ naive T cells could be readily converted to Foxp3+ (GFP+)
T cells (approximately 93%) after 5 days of culture. Similarly,
the mouse CD4+ central memory T cells readily converted to
Foxp3+ (GFP+) T cells (approximately 39%), although at a lower
rate than the CD4+ naive T cells. In addition, CD4+ effector
memory T cells were completely resistant to TGF-β-induced
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conversion, as previously reported (Figure 5A) [10]. To
investigate the function of the induced Foxp3+ T cells, we first
sorted GFP+ (Foxp3+) T cells by FACS within the pools of
mouse CD4+ naive or central memory T cells. After returning
them to culture, the CFSE-labelled responder T cells were
mixed with varying numbers of sorted GFP+(Foxp3+) T cells to
achieve the desired Foxp3+ T cells/T effector cell ratios. An
analysis of responder T cell proliferation with Foxp3+ T cells
showed that the Foxp3+ T cells derived from mouse CD4+
central memory T cells had clear suppressive function as
compared to the CD4+ naive T cell-derived Foxp3+ T cells, they
were really iTreg (Figure 5B).
Discussion
Adaptive Treg cells (iTreg) are known to be involved in
immune tolerance to foreign antigens and tumour-derived neo-
antigens. Multiple reports have demonstrated roles for iTreg in
mucosal immune tolerance, preventing the clearance of viruses
and other microorganisms and obstructing the elimination of
Figure 3.  More efficient induction of Foxp3+ T cells by CD4+CD62L+ central memory T cells than by other memory T cell
subsets.  (A) Sorted CD4+ central memory and effector memory T cells were activated with plate-bound anti-CD3 (5 μg/ml) and
soluble anti-CD28 (1 μg/ml) in the presence of TGF-β (5 ng/ml) and IL-2 (100 UI/ml) for 7 days. The induction of Foxp3+ T cells in
the CD4+ fraction was analysed by flow cytometry based on the intracellular staining of Foxp3.
(B-D) Tn indicates sorted CD4+ naive T cells, CD62L+ Tcm indicates sorted CD4+CD62L+ central memory T cells, CD62L+ Tem
indicates sorted CD4+CD62L+ effector memory T cells, and CD62L- Tem indicates sorted CD4+CD62L- effector memory T cells. The
results are one representative of three independent experiments.
(B) Flow cytometric analyses of the CD4+ naive and memory T-cell phenotypes.
(C) Sorted CD4+ naive, CD62L+ central memory, CD62L+ effector memory and CD62L- effector memory T cells were activated for 5
days as above and analysed by flow cytometry for Foxp3 expression in the indicated group of cells.
(D) The average percentages of Foxp3 expression by different subsets of memory T cells after induction by TGF-β and IL-2.
doi: 10.1371/journal.pone.0077322.g003
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tumours [4,29-33]. However, the detailed mechanisms
underlying their origin and differentiation are unknown.
Although CD4+Foxp3- naive T cells can be converted to iTreg
by TGF-β, the ability of CD4+ memory T cells to differentiate
into iTreg remains controversial. Some studies have reported
that human skin-derived CD4+ memory T cells and mouse
antigen-specific Th2 memory cells can be successfully
converted to CD4+Foxp3+ T cells in vitro [14,15], and our data
support this observation.
In the peripheral blood of chronic HBV-infected patients, the
percentage of CD4+Foxp3+ T cells was significantly higher than
in healthy controls, and the increased numbers of CD4+Foxp3+
T cells displayed the CD45RO+ memory cell phenotype. In
addition, although the in vitro differentiation efficiency of CD4+
memory T cells was significantly lower than that of the CD4+
naive T cells, there was a small subset of cells in the CD4+
memory T cell pool that could be converted to CD4+Foxp3+ T
cells. These data, combined with those of previous reports, led
us to hypothesise that a subset of CD4+ memory T cells might
serve as the origin of some CD4+Foxp3+ T cells in vivo. In this
study, we report a CD62L+CCR7+ subset of cells in the human
CD4+ memory T cell pool that efficiently differentiated into
CD4+Foxp3+ T cells by TCR stimulation with TGF-β and IL-2 in
vitro. We purified the indicated T-cell subsets from human
PBMCs and examined their in vitro differentiation efficiency by
flow cytometry analysis. Although the CD4+ memory T cells had
Figure 4.  Suppressive functions and methylation status of Foxp3+ T cells derived from human CD4+CD62L+ central
memory cells.  ‘Treg’ indicates sorted CD4+CD25high T cells, ‘Foxp3+ Tn’, ‘Foxp3+ Tcm’ and ‘Foxp3+ Tem’ indicate in vitro TGF-β-
induced Foxp3+ cells from naive, CD62L+ Tcm and CD62L- Tem CD4+ cells, respectively.
(A) CFSE-labelled allogeneic CD4+CD25- T cells (2.5×104) cultured alone or mixed with different ratios of suppressor cells (1:0, 1:1
and 2:1) were activated with plate-bound anti-CD3 (5 μg/ml) and soluble anti-CD28 (1 μg/ml) in 96-well plates for 5 days. The
suppressor cells were derived from naive, CD62+ Tcm and CD62L+ Tem cells that were induced to differentiate by the addition of TGF-
β. The results are one representative of three independent experiments.
(B) Electrophoresis of PCR (BSP) products sequenced with bisulphite. Treg indicates sorted CD4+CD25high T cells, Tn indicates
sorted CD4+ naive T cells, CD62L+ Tcm indicates sorted CD4+CD62L+ central memory T cells, Foxp3+ Tn indicates in vitro TGF-β-
induced Foxp3+ cells from CD4+ naive T cells, and Foxp3+ Tcm indicates in vitro TGF-β-induced Foxp3+ cells from CD4+CD62L+
central memory T cells.
(C) Analysis of FOXP3 TSDR methylation in cultured cells. Each line represents a clone, and every dot represents a CpG site in the
FOXP TSDR. A solid black dot indicates a methylated CpG site, while a hollow dot indicates a demethylated CpG site.
doi: 10.1371/journal.pone.0077322.g004
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Figure 5.  Induction of functional Foxp3+ T cells from mouse CD4+CD62L+ central memory T cells.  (A) FACS-sorted mouse
CD4 naive T cells (Tn), CD4 central memory T cells (Tcm) and CD4 effector memory T cells (Tem) were stimulated in vitro (1×105
cells/well) with anti-CD3 (2 μg/ml) and APCs (1×105 cells/well) in the presence of TGF-β (3 ng/ml) and IL-2 (100 U/ml) for 3–5 days.
The induction of Foxp3 in the CD4+ fraction was analysed by FACS based on GFP expression.
(B) CD4+ GFP- (Foxp3-) T cells were sorted from Foxp3gfp mice, labelled with CFSE and used as responder cells. The labelled T
cells (1×105 cells/well) were mixed with varying numbers of GFP+ (Foxp3+) T cells to achieve the desired Foxp3+ T cells/T effector
cell ratios. GFP+ (Foxp3+) T cells were sorted from CD4+ naive or central memory T cells through the induction of Foxp3. ‘iTreg’
indicates in vitro TGF-β-induced GFP+ cells from CD4+ naive T cells, and ‘iTregcm’ indicates in vitro TGF-β-induced GFP+ cells from
CD4+CD62L+ central memory T cells. The cell mixture was stimulated with syngeneic APCs (1×105 cells/well) and soluble anti-CD3
(1 μg/ml). Responder T cell proliferation with or without Foxp3+ T cells was assessed by CFSE dilution after 3 days of culture. The
results are one representative of three independent experiments.
doi: 10.1371/journal.pone.0077322.g005
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very low overall rates of differentiation into CD4+Foxp3+ T cells
in vitro, the CD4+ central memory T cells had a slightly higher
efficiency. We further identified a group of CD62L+ cells in the
central memory pool with an in vitro differentiation efficiency
that approached that of CD4+ naive T cells. However, an
epigenetic analysis showed that the CD4+Foxp3+ T cells
derived from CD62L+ central memory cells were more
methylated at the FOXP3 TSDR compared to the sorted Treg,
which could explain why these CD4+Foxp3+ T cells did not
exhibit suppressive functions. Additionally, we confirmed that
mouse CD62L+ central memory cells could readily convert to
Foxp3+ iTreg, and those iTreg had clear suppressive functions.
These new findings suggest that a particular subset of CD4+
memory T cells, defined as the CD62L+ central memory cells,
have the capacity to convert to CD4+Foxp3+ T cells.
In the case of HBV, higher levels of Treg have been
described [34]. It is well known that not all human Foxp3+ cells
are Treg, particularly under conditions of chronic cell activation,
such as a viral infection, where there may be a higher
proportion of effector T cells that transiently upregulate Foxp3
[35,36]. However, the frequency of total CD4+CD25+ T cells
was not significantly different between chronic HBV-infected
patients and healthy controls [37]. In addition, HBV-infected
patients in the inactive (IN) phase have low HBV DNA levels
(<2000 IU/ml) and normal ALT levels with minimal or absent
hepatic inflammation [38,39]. This indicates that CD4+ T cells
are not activated in chronic HBV-infected patients in the
inactive (IN) phase. Thus, the incremental CD4+Foxp3+ T cells
in the PBMCs of chronic HBV-infected patients in our study can
be considered to be induced Foxp3+ T cells. The increased
number of CD45RO+CD4+Foxp3+ T cells in chronic HBV-
infected patients may represent HBV-induced CD4+Foxp3+ T
cells because the CD4+ T cells were not activated in vivo.
Because Foxp3 expression is not induced during the
activation of mouse CD4+CD25- non-regulatory T cells, Foxp3
is considered to be the definitive marker of mouse nTreg, iTreg
generated in the periphery in vivo, and iTreg generated in vitro
in the presence of TGF-β [40]. In contrast, several studies have
claimed that this is not the case in humans. They suggest that
human CD4+CD25- T effector cells activated through TCR
stimulation alone with anti-CD3 and anti-CD28 show transiently
upregulated Foxp3 expression and demonstrate that this Foxp3
expression correlates with neither anergy nor suppressive
function [35,41-45]. In addition to confirming these previous
studies, our results shown in Figure 2A and Figure 3A reveal
new aspects involving Foxp3 expression. Consistent with
previous studies, upon stimulation with anti-CD3 and anti-
CD28, the memory CD4+CD25- T cells in our study transiently
upregulated their expression of Foxp3, and a dramatic increase
in the percentage of Foxp3+ cells was observed, with up to 18%
of the memory CD4+ T cells expressing Foxp3 on day 3 (Figure
2A). The proportion of Foxp3+ T cells then progressively
diminished over time to 7% by day 7. Interestingly, we found
that naive CD4+CD25- T cells did not always transiently
upregulate Foxp3 expression upon TCR stimulation alone with
anti-CD3 and anti-CD28. Previous studies based on human
CD4+CD25- T cells did not reveal this phenomenon, i.e., that
the transient upregulation of Foxp3 expression through TCR
stimulation alone without TGF-β is restricted to memory
CD4+CD25- T cells. Furthermore, memory (Tm), central
memory (Tcm), and effector memory (Tem) CD4+CD25- T cells
stimulated in the presence of TGF-β also showed an increase
in Foxp3 expression compared with those stimulated without
TGF-β (Figure 2A and Figure 3A). Although the effect of TGF-β
was not as strong in naive CD4 CD4+CD25- T cells, these
results still suggest that some memory CD4+CD25- T cells
respond to TGF-β-mediated Foxp3 expression.
Previous results have shown that the methylation status of
the FOXP3 TSDR is associated with the development of stable
Treg properties, and rare demethylation has been observed in
activated human conventional CD4+ T cells or in CD4+ naive T
cell-derived CD4+Foxp3+ T cells [20,27,46-48]. Our current data
clearly show that TGF-β-induced CD4+Foxp3+ T cells derived
from CD62L+ central memory cells exhibited high methylation
of CpG sites in the FOXP3 TSDR sequence. These results
may explain why the CD4+Foxp3+ T cells derived from the
CD62L+ central memory cells did not exhibit clear suppressive
functions (Figure 4A). It remains unclear why the FOXP3 TSDR
was not demethylated in these CD4+Foxp3+ T cells, but we can
speculate that the demethylation of the FOXP3 TSDR during
the formation of Treg is accomplished through a far more
complicated epigenomic regulatory network and involves the
coordination of multiple extracellular signals.
Our data indicate that CD62L+ central memory cells can
efficiently differentiate into CD4+Foxp3+ T cells. However, the
detailed mechanism of this differentiation is still unclear and
requires further study. We hypothesise that it is related to the
intrinsic constraints of the cells but not due to their similarity to
the CD4+ naive T-cell phenotype. Human CD4+ memory T cells
are not a uniform population, and they can be divided into the
two functionally distinct subsets of CCR7+ central memory and
CCR7- effector memory T cells [49]. There are significant
differences between these two subsets of cells, as illustrated
by their heterogeneity and effector functions, among other
factors [50,51]. Of note, CD4+ central memory and effector
memory cells have different capacities to produce cytokines.
Upon activation, CD4+ effector memory cells secrete high
levels of IL-4 and IFN-γ, which are not produced by activated
CD4+ central memory cells or CD4+ naive T cells [49].
Additionally, it is widely accepted that IL-4 and IFN-γ are the
major cytokines involved in the inhibition of TGF-β-induced
Foxp3 expression in CD4+CD25- T cells [9-11,52]. Therefore,
differences in cytokine secretion could potentially explain why
CD4+ central memory T cells can better differentiate into
Foxp3+ T cells.
In conclusion, we propose for the first time that CD4+CD62L+
central memory T cells can be induced to express Foxp3 by
TGF-β both in human and mouse, and obtained functional
Foxp3+ iTreg from mouse CD4+CD62L+ central memory T cells.
Our data suggested the possibility that iTreg might be derived
from activated CD4+CD62L+ central memory T cells in vivo, at
least in mouse. Thus, our study provides novel information on
the source of iTreg. Unfortunately, it seemed likely that we
failed to obtain functional Foxp3+ T cells from human
CD4+CD62L+ central memory T cells in this study. But
considering the induced Treg cells used for the assay were not
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purified FOXP3 expression T cells, they were a mixed
population of Foxp3+ T cells and activated T effector cells,
insufficient FOXP3 expression T cells added might lead to the
results we observed, their suppressive functions might be
obscured by mixed activated T effector cells. Our further
research confirmed this, induced Foxp3+ cells from naive and
CD62L+ central memory cells exhibited some suppressive
functions when the ratio (Teff cells/Foxp3+ T cells) was
increased (data not show), though their suppressive functions
were not apparent compared to that of Tregs directly isolated
from PBMCs. These findings suggested that such human
induced Foxp3+ cells might have suppressive functions. We will
further explore the suppressive functions of human Foxp3+
cells in our ongoing research.
Supporting Information
Figure S1.  Expression of CD45RA in the samples shown
in Figure 1E. Naive CD4+ T cells were sorted from adult
peripheral blood using FACS, and the cells were activated with
plate-bound anti-CD3 (5 μg/ml) and soluble anti-CD28 (1
μg/ml) in the absence or presence of TGF-β (5 ng/ml) and IL-2
(100 UI/ml) for 5 days. The cells were then collected and
analysed by flow cytometry to evaluate the expression of
Foxp3 and CD45RA.
(TIF)
Figure S2.  Expression of CD45RA and CD45RO in human
CD4+ T cells. Analysis of the CD45RA and CD45RO
expression on freshly isolated PBMCs FACS gated for CD4+ T
cells.
(TIF)
Figure S3.  Suppressive functions of Foxp3+ T cells
derived from human CD4+CD62L+ central memory cells.
‘Treg’ indicates sorted CD4+CD25high T cells, ‘Foxp3+ Tn’,
‘Foxp3+ Tcm’ and ‘Foxp3+ Tem’ indicate in vitro TGF-β-induced
Foxp3+ cells from naive, CD62L+ Tcm and CD62L- Tem CD4+
cells, respectively. CFSE-labelled allogeneic CD4+CD25- T
cells (2.5×104 cells/well) cultured alone or mixed with different
ratios of suppressor cells (1:0, 1:1 and 2:1) were activated with
anti-CD3 (5 μg/ml) and APCs (5×104 cells/well) in 96-well
plates for 5 days. The suppressor cells were derived from
naive, CD62+ Tcm and CD62L+ Tem cells that were induced to
differentiate by the addition of TGF-β.
(TIF)
Table S1.  Information for the human samples. Detailed
information regarding the human samples used in our study,
including age and sex.
(TIF)
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